Irvine, California
United States
42
2024-08-15
The entities that hold a legal rights for patent applications filed by inventor Wang Joanne:
Joanne Wang from Irvine, US has applied for patents for these inventions. The list has both pending applications and granted patents:
IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#2 | 2023-10-12CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#3 | 2023-09-28BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN
#4 | 2023-09-07IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#5 | 2023-07-27IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#6 | 2022-05-12IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#7 | 2021-11-04Immuno-based botulinum toxin serotype A activity assays
#8 | 2021-06-10IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS
#9 | 2021-06-10Immuno-based botulinum toxin serotype A activity assays
#10 | 2021-06-03CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#11 | 2021-06-03BOTULINUM NEUROTOXIN FOR TREATMENT OF DISORDERS ASSOCIATED WITH MELANOCYTE HYPERACTIVITY AND/OR EXCESS MELANIN
#12 | 2020-12-17IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#13 | 2020-11-26IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#14 | 2019-10-24Immuno-based retargeted endopeptidase activity assays
#15 | 2018-12-06Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
#16 | 2017-10-05Immuno-based botulinum toxin serotype A activity assays
#17 | 2017-08-31Immuno-based retargeted endopeptidase activity assays
#18 | 2017-08-03Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#19 | 2015-10-22Immuno-based retargeted endopeptidase activity assays
#20 | 2014-09-04Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A
#21 | 2014-04-03Cells useful for immuno-based botulinum toxin serotype a activity assays
#22 | 2013-10-10Immuno-Based Retargeted Endopeptidase Activity Assays
#23 | 2013-09-12Cells useful for immuno-based botulinum toxin serotype A activity assays
#24 | 2013-02-14IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#25 | 2012-09-06Immuno-based botulinum toxin serotype A activity assays
#26 | 2012-08-23Cells useful for immuno-based botulinum toxin serotype A activity assays
#27 | 2012-08-23Cells useful for immuno-based botulinum toxin serotype A activity assays
#28 | 2012-08-16Cells useful for immuno-based botulinum toxin serotype A activity assays
#29 | 2012-08-16Cells useful for immuno-based botulinum toxin serotype A activity assays
#30 | 2012-06-28Cells useful for immuno-based botulinum toxin serotype A activity assays
#31 | 2012-06-21Cells useful for immuno-based botulinum toxin serotype A activity assays
#32 | 2012-06-21Cells useful for immuno-based botulinum toxin serotype A activity assays
#33 | 2012-06-21Cells useful for immuno-based botulinum toxin serotype A activity assays
#34 | 2012-06-21Cells useful for immuno-based Botulinum toxin serotype A activity assays
#35 | 2012-06-14Cells useful for immuno-based botulinum toxin serotype A activity assays
#36 | 2012-06-14Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#37 | 2012-06-14Cells useful for immuno-based botulinum toxin serotype A activity assays
#38 | 2012-06-14Cells Useful for Immuno-Based Botulinum Toxin Serotype A Activity Assays
#39 | 2012-05-17Immuno-based botulinum toxin serotype A activity assays
#40 | 2010-09-16Cells useful for immuno-based Botulinum toxin serotype A activity assays
#41 | 2010-09-16Immuno-based retargeted endopeptidase activity assays
#42 | 2010-08-12Immuno-based botulinum toxin serotype A activity assays
90392 ⎘